-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Basroparib in Kidney Cancer (Renal Cell Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Basroparib in Kidney Cancer (Renal Cell Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Basroparib in Kidney Cancer (Renal Cell Cancer) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ixabepilone in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ixabepilone in Fallopian Tube Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ixabepilone in Fallopian Tube Cancer Drug Details: Ixabepilone (Ixempra, Ixemprya)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ixabepilone in Peritoneal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ixabepilone in Peritoneal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ixabepilone in Peritoneal Cancer Drug Details: Ixabepilone (Ixempra, Ixemprya) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ixabepilone in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ixabepilone in Epithelial Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ixabepilone in Epithelial Ovarian Cancer Drug Details: Ixabepilone (Ixempra, Ixemprya)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Paclitaxel in Head And Neck Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Paclitaxel in Head And Neck Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Paclitaxel in Head And Neck Cancer Drug Details: Paclitaxel...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BDB-201 in Metastatic Liver Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BDB-201 in Metastatic Liver Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BDB-201 in Metastatic Liver Cancer Drug Details: Orien X-010 (BDB-201)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anvatabart Opadotin in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anvatabart Opadotin in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anvatabart Opadotin in Solid Tumor Drug Details: Anvatabart opadotin (ARX-788)...
-
Product Insights
NewQuarterly Sweet Spreads pricing trends in Spain
Empower your strategies with our Quarterly Sweet Spreads pricing trends in Spain report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Conestat Alfa in Acute Ischemic Stroke
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Conestat Alfa in Acute Ischemic Stroke report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Conestat Alfa in Acute Ischemic Stroke Drug Details: Conestat...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pacmilimab in Thymic Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pacmilimab in Thymic Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pacmilimab in Thymic Carcinoma Drug Details: CX-072 is under development for...